Many publications have shown that the serum levels of HE4 and CA125 can be used for the early detection of ovarian cancer recurrence and to classify patients with a pelvic mass as at high or low risk of ovarian malignancy [18,19]. Here, WFDC2 is linked to ovarian carcinoma.